22nd Century Group to Present at the Virtual Fall Investor Summit on November 17
WILLIAMSVILLE, N.Y., Nov. 16, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very low nicotine content tobacco, and hemp/cannabis research, announced today that the Company will present and meet with investors at the Virtual Fall Investor Summit. The conference is being held virtually November 16 -18, 2020.
22nd Century is scheduled to present on Tuesday, November 17, 2020 at 4:30 p.m. ET. The live webcast and presentation will be accessible in the Investors section of 22nd Century’s website under Events. An archived replay of the webcast will be available shortly after the live event.
Please visit https://investorsummitgroup.com/ to register for the conference and schedule one-on-one meeting with 22nd Century.
About 22nd Century Group, Inc.
22nd Century Group, Inc. (NYSE American: XXII) is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding. 22nd Century’s primary mission in tobacco is to reduce the harm caused by smoking through the Company’s proprietary reduced nicotine content tobacco cigarettes – containing 95% less nicotine than conventional cigarettes. The Company’s primary mission in hemp/cannabis is to develop and commercialize proprietary hemp/cannabis plants with valuable cannabinoid profiles and desirable agronomic traits.
Investor Relations & Media Contact:
Director, Communications & Investor Relations
22nd Century Group, Inc.
Released November 16, 2020